METABOLIC ANALYSIS OF GLIOBLASTOMA XENOGRAFTS AFTER ANTI-ANGIOGENIC TREATMENT

被引：0
|
作者：
Fack, F. [1 ]
Zheng, L. [2 ]
Frezza, C. [2 ]
Keunen, O. [1 ]
Kalna, G. [2 ]
Nazarov, P. [3 ]
Gottlieb, E. [2 ]
Niclou, S. P. [1 ]
Bjerkvig, R. [1 ,4 ]
机构：
[1] CRP Sante, NorLux Neurooncol Lab, Luxembourg, Luxembourg
[2] Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland
[3] CRP Sante, Microarray Ctr, Luxembourg, Luxembourg
[4] Univ Bergen, Bergen, Norway
来源：
NEURO-ONCOLOGY | 2012年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：58 / 58
页数：1
相关论文
共 50 条
  • [31] Anti-angiogenic treatment of gastrointestinal malignancies
    Salmon, JS
    Lockhart, AC
    Berlin, J
    CANCER INVESTIGATION, 2005, 23 (08) : 712 - 726
  • [32] Anti-angiogenic treatment and colorectal cancer
    Andre, Thierry
    Tournigand, Christophe
    Abbas, Fadi
    Louvet, Christophe
    de Gramont, Airnery
    BULLETIN DU CANCER, 2007, 94 : S211 - S219
  • [33] Magnetic resonance spectroscopic imaging for detecting metabolic changes in glioblastoma after anti-angiogenic therapy-a systematic literature review
    El-Abtah, Mohamed E.
    Talati, Pratik
    Dietrich, Jorg
    Gerstner, Elizabeth R.
    Ratai, Eva-Maria
    NEURO-ONCOLOGY ADVANCES, 2022, 4 (01)
  • [34] Exploring the Past, Present, and Future of Anti-Angiogenic Therapy in Glioblastoma
    Zhang, Ashley B. B.
    Mozaffari, Khashayar
    Aguirre, Brian
    Li, Victor
    Kubba, Rohan
    Desai, Nilay C.
    Wei, Darren
    Yang, Isaac
    Wadehra, Madhuri
    CANCERS, 2023, 15 (03)
  • [35] Mechanisms of Tumor Development and Anti-angiogenic Therapy in Glioblastoma Multiforme
    Onishi, Manabu
    Kurozumi, Kazuhiko
    Ichikawa, Tomotsugu
    Date, Isao
    NEUROLOGIA MEDICO-CHIRURGICA, 2013, 53 (11) : 755 - 763
  • [36] Mechanisms of neovascularization and resistance to anti-angiogenic therapies in glioblastoma multiforme
    Yasushi Soda
    Chad Myskiw
    Amy Rommel
    Inder M. Verma
    Journal of Molecular Medicine, 2013, 91 : 439 - 448
  • [37] Identification of the hidden survival advantage for anti-angiogenic therapy in glioblastoma
    Nabors, Burt
    TRANSLATIONAL CANCER RESEARCH, 2016, 5 (01) : 72 - 74
  • [38] A is for anti-angiogenic
    不详
    NATURE MEDICINE, 2001, 7 (04) : 418 - 418
  • [39] Cediranib: profile of a novel anti-angiogenic agent in patients with glioblastoma
    Dietrich, Joerg
    Wang, Daphne
    Batchelor, Tracy T.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2009, 18 (10) : 1549 - 1557
  • [40] Development of an anti-angiogenic targeted toxin against glioblastoma multiforme
    Hall, WA
    Rustamzadeh, E
    Liu, H
    Vallera, DA
    EUROPEAN JOURNAL OF CANCER, 2002, 38 : S124 - S124
12345